MedTrace Logo

Studying Biomarkers in Blood Samples From Patients With Invasive Cervical Cancer

NCT01074424 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 84

Last updated 2010-02-24

No results posted yet for this study

Summary

RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors identify and learn more about biomarkers related to cancer. It may also help doctors predict how well patients will respond to treatment.

PURPOSE: This research study is looking at biomarkers in blood samples from patients with invasive cervical cancer.

Conditions

Interventions

GENETIC

proteomic profiling

OTHER

laboratory biomarker analysis

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Gynecologic Oncology Group

    lead NETWORK

Principal Investigators

  • Samir N. Khleif, MD · National Cancer Institute (NCI)

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-02-28
Primary Completion
2010-03-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01074424 on ClinicalTrials.gov